Study Results Reveal Potential Genetic Profiling for Prescribing ACE Inhibitors

Although the study results require further validation, "if confirmed in subsequent studies, our findings open the route to individualize therapy by pharmacogenetic profiling," study authors said in a statement discussing their analysis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.